Imerys


CAPITAL GOODS SEES NO LIGHT

22/09/22 -"With reasonably full orderbooks and unique competences exported the world over, European Capital Goods providers would have been expected to be comparatively more resilient to a European looming ..."

Pages
61
Language
English
Published on
22/09/22
You may also be interested by these reports :
04/10/22
CMD highlights: 1) confident management statements despite challenges, 2) FY22 guidance lifted & 2023 targets reconfirmed, 3) MBCC on track

04/10/22
Upside potential as large cap quality is likely to be in demand

22/09/22
A week ago, we published a special report on a speciality building materials player Imerys (Buy, France) – about how it can surf on the lithium-ion ...

20/09/22
Strategic shift towards Li-ion batteries

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO